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Abstract
Background: The aim of this study was to evaluate the combination of a rapid intravenous infusion
of cold saline and endovascular hypothermia in a closed chest pig infarct model.
Methods:  Pigs were randomized to pre-reperfusion hypothermia (n = 7), post-reperfusion
hypothermia (n = 7) or normothermia (n = 5). A percutaneous coronary intervention balloon was
inflated in the left anterior descending artery for 40 min. Hypothermia was started after 25 min of
ischemia or immediately after reperfusion by infusion of 1000 ml of 4°C saline and endovascular
hypothermia. Area at risk was evaluated by in vivo SPECT. Infarct size was evaluated by ex vivo MRI.
Results: Pre-reperfusion hypothermia reduced infarct size/area at risk by 43% (46 ± 8%) compared
to post-reperfusion hypothermia (80 ± 6%, p < 0.05) and by 39% compared to normothermia (75
± 5%, p < 0.05). Pre-reperfusion hypothermia infarctions were patchier in appearance with
scattered islands of viable myocardium. Pre-reperfusion hypothermia abolished (0%, p < 0.001), and
post-reperfusion hypothermia significantly reduced microvascular obstruction (10.3 ± 5%; p <
0.05), compared to normothermia: (30.2 ± 5%).
Conclusion: Rapid hypothermia with cold saline and endovascular cooling before reperfusion
reduces myocardial infarct size and microvascular obstruction. A novel finding is that hypothermia
at the onset of reperfusion reduces microvascular obstruction without reducing myocardial infarct
size. Intravenous administration of cold saline combined with endovascular hypothermia provides
a method for a rapid induction of hypothermia suggesting a potential clinical application.
Background
Modern reperfusion therapy of acute myocardial infarc-
tion is aimed at performing primary percutaneous coro-
nary intervention (PCI) in order to reduce myocardial
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infarct size and the extent of complications [1-3].
Although restoration of blood flow to the jeopardized
myocardium is a prerequisite for myocardial salvage,
reperfusion in itself may lead to accelerated and addi-
tional myocardial injury beyond that generated by
ischemia alone, a phenomenon referred to as "reperfusion
injury" [4,5]. Furthermore, myocardial ischemia damages
the endothelium causing impairment of the microvascu-
lar blood flow (microvascular obstruction). In the clinical
setting, microvascular obstruction is common and associ-
ated with a worse clinical outcome. [6]
Consequently, there is a need for an adjunctive therapy for
myocardial salvage beyond that which modern reper-
fusion therapy can provide. There are several experimental
pharmacological therapies which have shown to protect
the myocardium from ischemic injury; however for vari-
ous reasons, no therapy has yet reached clinical practice
[7]. Hypothermia as a possible therapeutic option in treat-
ing myocardial infarction has in experimental studies
shown beneficial results [8-14]. Furthermore, Hale et al
have demonstrated that hypothermia reduces the extent
of microvascular obstruction [15]. However, local cooling
just before reperfusion did not reduce infarct size [10].
Two randomized clinical trials investigating the effects of
hypothermia as an adjunct therapy to PCI in patients with
acute myocardial infarction failed to show positive results
[16,17]. However, post hoc analysis of the patients who
reached a temperature of < 35°C before reperfusion
showed a reduction in infarct size suggesting the benefit of
induction of hypothermia before reperfusion. Due to the
large body mass of humans in the clinical setting it is dif-
ficult to achieve adequate hypothermia without delaying
reperfusion therapy. With external cooling or endovascu-
lar cooling alone it takes 30 min to 1 h for the patients to
reach target temperature [8,18-20]. The aim of this study
was to investigate whether rapid induction of hypother-
mia before reperfusion (pre-reperfusion hypothermia)
would reduce infarct size in a closed chest pig model. We
also wanted to test this hypothesis with a clinically appli-
cable treatment protocol that would achieve a rapid cool-
ing to target temperature in less than 15 minutes. We
therefore combined an infusion of cold saline together
with endovascular cooling in order to achieve rapid cool-
ing and compared it with hypothermia induced immedi-
ately after reperfusion (post-reperfusion hypothermia) or
normothermia. Based on the results from previous clinical
trials our hypothesis was that hypothermia had to be
induced before reperfusion in order to reduce myocardial
injury.
Methods
Ethics
The study conforms to the Guide for the Care and Use of
Laboratory Animals, US National Institute of Health (NIH
Publication No. 85–23, revised 1996) and was approved
by the Ethics Committee of Lund University, Sweden.
Experimental preparation
22 healthy domestic male and female pigs weighing 40–
50 kg were fasted overnight with free access to water and
were premedicated with Ketaminol (Ketamine, Intervet,
Danderyd, Sweden), 100 mg/ml, 1,5 ml/10 kg, and
Rompun (Xylazin, Bayer AG, Leverkusen, Germany), 20
mg/ml, 1 ml/10 kg intramuscularly 30 min before the
procedure. After induction of anesthesia with thiopental
12.5 mg/kg (Pentothal, Abbott, Stockholm, Sweden), the
animals were orally intubated with cuffed endotracheal
tubes. A slow infusion of 1 µ l/ml Fentanyl (Fentanyl,
Pharmalink AB, Stockholm, Sweden) in buffered glucose
(25 mg/ml) was started at a rate of 2 ml/min and adjusted
as needed. Anesthesia was complemented with small
intermittent doses of thiopental (Pentothal, Abbott,
Stockholm, Sweden), 50 mg/ml, 1–2 ml when needed.
Mechanical ventilation was established with a Siemens-
Elema 900B ventilator in the volume-controlled mode,
adjusted in order to obtain normocapnia (pCO2: 5.0–6.0
kPa). The animals were ventilated with a mixture of
nitrous oxide (70%) and oxygen (30%). Analysis of arte-
rial bloodgases in order to adjust ventilation was per-
formed before initiation of ischemia, and once during
ischemia. The pigs were continuously monitored with
electrocardiogram (ECG). Heparin (200 IU/kg) was given
intravenously at the start of the catheterization. A 12 F
introducer sheath (Boston Scientific Scimed, Maple
Grove, MN, USA) was inserted into the surgically exposed
left femoral vein. Through the introducer a 0.021-inch
guide wire (Safe-T-J Curved™, Cook Medical Inc, Bloom-
ington, IN, USA) was inserted into the proximal inferior
vena cava. Using the guide wire, a 10.7 F Celsius Control™
catheter (Innercool Therapies Inc, San Diego, CA, USA)
was then placed into the inferior vena cava with the tip of
the catheter at the level of the diaphragm. Body tempera-
ture was measured with a temperature probe (TYCO
Healthcare Norden AB, Solna, Sweden) placed in the dis-
tal part of the esophagus. The catheter and the tempera-
ture probe were then connected to the Celsius Control
and the system was set to maintain a normal pig body
temperature of 38.0°C. A 6 F introducer sheath (Boston
Scientific Scimed, Maple Grove, MN, USA) was then
inserted into the surgically exposed left carotid artery
upon which a 6 F JL4 Wiseguide™ (Boston Scientific Sci-
med, Maple Grove, MN, USA) was inserted into the left
main coronary artery. The catheter was used to place a
0.014-inch PT Choice™ guide wire (Boston Scientific Sci-
med, Maple Grove, MN, USA) into the distal portion of
the LAD. A 3.0 × 20 mm Maverick monorail™ angioplasty
balloon (Boston Scientific Scimed, Maple Grove, MN,
USA) was then positioned in the mid portion of the LAD,
immediately distal to the first diagonal branch. All radio-BMC Cardiovascular Disorders 2008, 8:7 http://www.biomedcentral.com/1471-2261/8/7
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logical procedures were performed in an experimental
catheterization laboratory (Shimadzu Corp., Kyoto,
Japan).
Ischemia protocol
After a stable core body temperature of 38.0°C was
achieved, ischemia was induced by inflation of the angi-
oplasty balloon for 40 min. An angiogram was performed
after inflation of the balloon and before deflation of the
balloon in order to verify total occlusion of the coronary
vessel and correct balloon positioning. After deflation of
the balloon a subsequent angiogram was performed to
verify restoration of blood flow in the previously occluded
artery.
Hypothermia protocol
The pigs were randomized by drawing folded paper notes
out of a box to rapid hypothermia before reperfusion,
(pre-reperfusion hypothermia, n = 8) or immediately after
reperfusion (post-reperfusion hypothermia, n = 8). A nor-
mothermic group (n = 6) was also studied in order to pro-
vide comparison between different hypothermia
protocols and normothermia. Hypothermia was induced
by a rapid intravenous infusion of 1000 ml of 4°C cold
saline into a central vein together with the Celsius Con-
trol™ endovascular cooling system after 25 min of
ischemia or immediately after reperfusion when coronary
blood flow was restored (Figure 1). Target temperature
was 33°C and successful cooling was defined as a temper-
ature of = 35°C. Hypothermia was then actively main-
tained for 30 min followed by passive rewarming with
blankets.
In vivo assessment of area at risk by SPECT
Single photon emission computed tomography (SPECT)
was used to assess the area at risk (AAR). Five hundred
MBq of 99mTc-tetrofosmin was administered intrave-
nously ten minutes before deflation of the angioplasty
balloon. The anesthetized pigs were then imaged in a
supine position with a dual head camera (ADAC Vertex,
Milpitas, CA, USA) at 32 projections (40 s per projection)
with a 64 × 64 matrix yielding a digital resolution of 5 × 5
× 5 mm. Iterative reconstruction using maximum likeli-
hood-expectation maximization (MLEM) was performed
with a low-resolution Butterworth filter with a cut-off fre-
quency set to 0.6 of Nyquist and order 5.0. No attenuation
or scatter correction was applied. Finally short and long-
axis images were reconstructed. Quantification of the size
of AAR in ml was performed automatically as the extent of
the perfusion defect as determined by commercially avail-
able software (Auto QUANT™ 4.3.1 and a standard data-
base; ADAC, Milpitas, CA, USA) [21]. AAR was expressed
as percent of the left ventricular volume, and this was
determined by dividing the AAR (ml) from SPECT by the
left ventricular wall volume (ml) determined by ex vivo
MRI as described below. This was performed due to the
known limitations in accuracy for determining left ven-
tricular wall volume by SPECT [22].
In-vivo measurement of cardiac output and stroke volume
Cardiac output was assessed by magnetic resonance flow
imaging of a cross section of the pulmonary trunk using a
velocity encoded gradient echo sequence with retrospec-
tive ECG triggering. Typical imaging parameters were:
slice thickness 6 mm, number of time frames per cardiac
cycle 35, echo time 5.6 ms, repetition time 9.0 ms, spatial
resolution 1.5 × 1.5 × 8 mm, velocity encoding gradient
(VENC) 200 cm/s, flip angle 15°. Image analysis for flow
quantification was performed according to established
techniques [23] using freely available software Segment
1.611 [24].
Infarct size and microvascular obstruction assessed by ex 
vivo MRI
Ex vivo imaging of the heart was undertaken using a 1.5 T
Philips Intera CV MR scanner (Philips, Best, the Nether-
lands) according to a previous described protocol [25]. In
brief, a commercially available gadolinium-based contrast
agent (Magnevist, gadopentetate dimeglumine, Gd-DTPA,
Schering Nordisker AB, Järfälla, Sweden) was adminis-
tered intravenously (0.2 mmol/kg) both 60 and 15 min-
utes prior to removal of the heart. After removal, the heart
was immediately rinsed in cold saline and the ventricles
were filled with balloons containing deuterated water.
Three dimensional acquisition of T1-weighted images (TR
Protocol for induction of hypothermia Figure 1
Protocol for induction of hypothermia. In the pre-
reperfusion group, hypothermia was started after 25 min of 
ischemia (15 min before reperfusion) and in the post-reper-
fusion group, hypothermia was started immediately after 
reperfusion. The normothermic group was maintained at 
38.0°C.
Post-reperfusion hypothermia
Induction of hypothermia
Pre-reperfusion hypothermia
Ischemia (40 min)
Normothermia (38OC)
Normothermia
Ischemia (40 min)
Normothermia (38OC) Hypothermia (33OC)
Ischemia (40 min)
Normothermia (38OC)
Normothermia (38° C)
Induction of hypothermia
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= 20 ms, TE = 3.2 ms, flip angle = 70° and 2 averages)
yielded a stack of approximately 200 images with an iso-
metric resolution of 0.5 mm covering the entire heart.
Images were then acquired using a head coil and the dura-
tion of acquisition was typically 45 minutes.
The MR images were analyzed using freely available soft-
ware [26]. The endocardial and epicardial borders of the
left ventricular myocardium were manually delineated in
short-axis ex vivo images. This defined the volume of left
ventricular myocardium (cm3 = ml). The infarct size (IS)
was first determined as the volume of infarcted myocar-
dium (cm3). The infarct volume was calculated as the
product of the slice thickness (cm) and the area of hyper-
enhanced pixels (cm2) with a signal intensity above the
infarction threshold defined as >8 SD above the mean
intensity of non-affected remote myocardium. Microvas-
cular obstruction was defined as hypointense regions in
the core of the infarction which had signal intensity less
than the threshold for infarction. These regions were man-
ually included in the infarct volume. The volume of
microvascular obstruction (cm3) was calculated as the dif-
ference between the infarct volume before and after man-
ual inclusion of regions of microvascular obstruction.
Furthermore, the size of microvascular obstruction was
expressed as percent of the total infarct volume. Ulti-
mately, the infarct size was expressed as percent of left
ventricular myocardium.
One animal in the normothermia group suffered from
severe bradycardia which required manual open chest car-
diac compression in order to secure the adequate circula-
tion of the second injection of contrast media. The remote
myocardium was somewhat increased in signal intensity
and the threshold for infarction in this animal was there-
fore defined as pixels which were 3SD above the remote
myocardium as determined by visual assessment. Finally,
infarct size was expressed as a percentage of the area at risk
(IS/AAR) in order to adjust for any difference in area at
risk between the groups [27,28].
Patchiness index
Infarct homogeneity was assessed by a patchiness index
based on infarct surface area. The high resolution ex vivo
MR images allowed quantification of the surface area of
the infarct. Infarct surface area (cm2) was automatically
determined as the product of the slice thickness (cm) and
the distance along the pixel border between infarcted and
non-infarcted pixels (cm) in each slice. For equally homo-
geneous infarcts, a larger infarct volume will yield a larger
surface area. A dimensionless patchiness index was there-
fore calculated as the infarct surface area (cm2) to the
power of 3/2, divided by the infarct volume (cm3) Thus,
the patchiness index provided a method for estimating the
homogeneity of the myocardial infarction adjusted for
infarct size.
Calculation and statistics
Calculations and statistics were performed using the
GraphPad Prism 4.0 software. Values are presented as
mean ± SEM. Statistical significance was accepted when P
< 0.05 Non-parametric ANOVA (Kruskal-Wallis test) fol-
lowed by Dunn's post test was used.
Results
One pig in the pre-reperfusion hypothermia group died of
intractable ventricular fibrillation shortly after initiation
of ischemia. One pig in the post-reperfusion hypothermia
group died of pulseless electrical activity 30 min after ini-
tiation of ischemia. One pig in the normothermia group
died of pulseless electrical activity 15 min after initiation
of ischemia. Thus, seven pigs in the pre-reperfusion hypo-
thermia group, seven pigs in the post-reperfusion hypo-
thermia group, and five pigs in the normothermia group
were available for analysis.
Temperature measurements
Measurements of core temperature during the experiment
are shown in figure 2. At the time of balloon inflation
there was no difference in temperature between the
groups. In approximately five minutes after initiation of
hypothermia, the temperature had been lowered to below
35.0°C in all animals. There was a significant difference in
temperature at the time of reperfusion between the hypo-
thermia groups (pre-reperfusion hypothermia: 34.2 ±
0.4°C; post-reperfusion hypothermia: 37.8 ± 0.2°C; p <
0.001).
Arrhytmias
The occurrence of ventricular tachycardia/fibrillation dur-
ing ischemia and at the onset of reperfusion was recorded.
VT/VF occurred in 6/7 pigs in the pre-reperfusion hypo-
thermia group, in 3/7 pigs in the post-reperfusion hypo-
thermia group and in 3/5 pigs in the normothermic
group.
Heart rate, cardiac output and stroke volume
In-vivo MRI was performed on all pigs for measurement
of functional data after ischemia. MRI was performed ~45
min before removal of the heart for subsequent analysis of
infarct size. In 7 pigs a baseline MRI was performed 2 h
before induction of ischemia. Heart rate was 63 ± 6 bpm
at baseline (no difference between groups). At the time of
MRI the heart rates were: 76 ± 7 bpm (pre-reperfusion
hypothermia), 93 ± 8 bpm (post-reperfusion hypother-
mia) and 118 ± 12 bpm (normothermia). Stroke volume
was 41 ± 1 ml at baseline (no difference between groups).
At the time of MRI, stroke volumes were: 24 ± 3 ml (pre-
reperfusion hypothermia), 25± 3 ml (post-reperfusionBMC Cardiovascular Disorders 2008, 8:7 http://www.biomedcentral.com/1471-2261/8/7
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hypothermia) and 24 ± 5 ml (normothermia). Cardiac
output was 2.5 ± 0.2 l/min at baseline (no difference
between groups). At the time of MRI cardiac output was:
1.8 ± 0.2 l/min (pre-reperfusion hypothermia), 2.2 ± 0.2
l/min (post-reperfusion hypothermia) and 2.7 ± 0.5 l/min
(normothermia). There was no significant difference in
cardiac output or stroke volume between the different
groups (p = 0.076).
Area at risk and infarct size
The heart was removed 4 h 22 min ± 47 min after initia-
tion of reperfusion. There was no difference in removal
time between the different groups (p = 0.22). As shown in
figure 3a there was no difference in size of area at risk
(AAR) between the groups (pre-reperfusion hypothermia:
39 ± 3%, post-reperfusion hypothermia: 35 ± 3%, normo-
thermia: 42 ± 4%, (p = 0.26). Hypothermia treatment
caused a significant reduction in relative infarct size (IS/
AAR), (p = 0.02) between the different groups, pre-reper-
fusion hypothermia (46 ± 8%), post-reperfusion hypo-
thermia (80 ± 6%), and normothermic controls (75 ± 5),
(Figure 3b). The relative reduction in IS/AAR was 39%
between pre-reperfusion hypothermia and normothemic
controls and by 43% between pre-reperfusion hypother-
mia and post-reperfusion hypothermia. There was no sig-
nificant difference in IS/AAR between post-reperfusion
hypothermia and normothermia (p > 0.05). The infarct
volume as percent of left ventricular volume (uncorrected
for AAR) also differed markedly (p = 0.001): pre-reper-
fusion hypothermia: 17.1 ± 2% (% of left ventricle) com-
pared to post-reperfusion hypothermia 27.7 ± 3% (p <
0.05), and normothermia 31.4 ± 4% (p < 0.01), (Figure
3c). Furthermore, 6 out of 7 pigs in the post-reperfusion
hypothermia group and all 5 pigs in the normothermia
group had hypointense zones in the infarction, typical for
microvascular obstruction. None of the 7 pigs in the pre-
reperfusion hypothermia group displayed microvascular
obstruction (Figure 3d). The difference in size of the
regions of microvascular obstruction was also significant
(p < 0.001): Pre-reperfusion hypothermia, 0% compared
to post-reperfusion hypothermia (10.3 ± 5%; p < 0.05),
pre-reperfusion hypothermia compared to normother-
mia: (30.2 ± 5%; p < 0.001), but also between post-reper-
fusion hypothermia and normothermia (p < 0.05).
Patchiness
In the pre-reperfusion hypothermia group a patchy
appearance of the myocardial infarctions was observed
(Figure 4). In contrast, in the post-reperfusion hypother-
mia and normothermia groups the infarctions were more
homogeneous in appearance. There was a significant dif-
ference in the previously described patchiness index
between the groups (p = 0.002): pre-reperfusion hypo-
thermia (241.8 ± 50.6) compared to compared to normo-
thermia (74.3 ± 5.1; p < 0.01). There was no significant
difference in patchiness index between pre-reperfusion
hypothermia and post-reperfusion hypothermia (104.7 ±
5.5; p > 0.05), or between post-reperfusion hypothermia
and normothermia (p > 0.05).
Discussion
This study demonstrates that a combination of cold saline
and endovascular cooling achieves a rapid induction of
hypothermia which before reperfusion reduces myocar-
dial infarct size in pigs by 43% compared to hypothermia
immediately at the onset of reperfusion, and by 39% com-
pared to normothermia. The infarctions were patchier in
appearance with scattered islands of viable myocardium.
For the first time we demonstrate that hypothermia at the
onset of reperfusion reduces microvascular obstruction
without reducing myocardial infarct size.
Catheter based closed chest pig infarction model
All animal models have advantages and limitations. Sev-
eral previous studies have used open chest models which
cause a prominent operation-induced stress reaction and
change the physiological situation markedly. A percutane-
ous catheter-based approach was chosen in order to
induce ischemia with minimum trauma. The ischemia
time of 40 min is shorter than in the typical patient with
myocardial infarction with usually at least 2–4 hours
duration before start of treatment. However, healthy pigs
develop myocardial infarction more rapidly than humans
[27-29], and a longer duration of ischemia would result in
a large established infarct before hypothermia and reper-
fusion. In order to avoid a spontaneous variation in tem-
perature during the experiment, normal core body
Core body temperature (esophageal) measurements in the  different groups Figure 2
Core body temperature (esophageal) measurements 
in the different groups. The combination of infusion of 
cold saline with endovascular cooling caused a rapid reduc-
tion in core body temperature. Data are expressed as mean 
± SEM.
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temperature in pig (38°C) was established before induc-
tion of ischemia. In subgroup analysis of clinical trials a
pre-reperfusion temperature of <35°C was sufficient to
reduce infarction size by approximately 40% [16,17].
Based on the results, 33°C was chosen as target tempera-
ture, and the limit for successful hypothermia was 35°.
The difference in temperature between the hypothermia
groups was 3.6°C (37.8°C vs. 34.2°C) at the time of
reperfusion. Thus, a reduction of core body temperature
of 3.6°C before reperfusion was enough to reduce infarct
size by 43%. These results are in agreement with previous
studies with more long-term hypothermia during
ischemia in which reductions in temperature of 3–5°C
had prominent effects [8-14].
Rapid cooling before reperfusion
One of the limitations of previous experimental studies is
that animals have been subject to hypothermia before or
early after induction of ischemia. In the clinical setting
this is not applicable since it will only be possible to
induce hypothermia shortly before or after reperfusion.
Our findings are in agreement with a study by Maeng et al
in which post-reperfusion hypothermia did not reduce
infarct size [30]. In contrast to our findings, Hale and co-
workers did not see any effect of local cooling just before
reperfusion on infarct size [10]. They cooled during the
final 5 min of 30 min ischemia, while we achieved = 35°C
during the final 10 min of 40 min ischemia. These time
differences may partly explain the difference in effect.
(a) Size of area at risk (AAR) by SPECT Figure 3
(a) Size of area at risk (AAR) by SPECT. There was no difference in AAR between the different groups. (b) Infarct size 
(IS) measured by ex-vivo MRI as a percentage of area at risk (AAR) by SPECT in the two groups. Pre-reperfusion hypothermia 
causes a 43% relative reduction in infarct size compared to post-reperfusion hypothermia and by 39% compared to normoth-
ermia. (c) Infarct size (IS) measured by ex vivo MRI, expressed as a percentage of the left ventricular mass. (d) Microvascular 
obstruction measured by ex vivo MRI, expressed as a percentage of the infarct size. Pre-reperfusion hypothermia totally abol-
ished microvascular obstruction. Post-reperfusion hypothermia significantly decreased the extent of micovascular obstruction 
compared to normothermia. (* = p < 0.05, ** = p < 0.01, *** = p < 0.001). Data are expressed as mean ± SEM.
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They used topical cooling in an open chest model in rab-
bits. It is possible that rapid cooling from within using
cold fluids combined with an intravenous catheter is
more efficient. It cools primarily the most vulnerable part,
the endocardium. First, cold blood passes through the
right ventricle and the septum is cooled, then the whole
left ventricle is cooled from the inside and last via the cor-
onary circulation. Coronary circulation cooling is proba-
bly the least important because the artery to the affected
vessel is occluded, limiting access to hypothermic fluids to
the ischemic part of the myocardium.
The observed reduction in infarct size may be attributed to
the protective effects of hypothermia during the last part
of the ischemia. Hypothetically, it may also be an effect of
a reduction in reperfusion injury. Our group has previ-
ously shown that hypothermia reduces postischemic cor-
onary reactive hyperemia [31]. Regardless of the
mechanism, the protective properties of hypothermia
demonstrated in this study and previous studies indicate
a potential clinical benefit of hypothermia. A major
advantage of this protocol is the feasibility of "kick-start-
ing" the hypothermia treatment using cold saline which
achieves a quick cooling to target temperature. Secondly,
cold saline is a low tech solution which could be admin-
istered in the ambulance, thereby inducing hypothermia
before the patient reaches the cath-lab, which would fur-
ther limit the normothermic ischemic time.
Post hoc analysis of the COOL-MI and ICE-IT trials dem-
onstrated that only those patients who reached target tem-
perature before reperfusion displayed a benefit of
hypothermia [16,17]. These results suggest the necessity
of inducing hypothermia before reperfusion. However,
with endovascular cooling alone it takes 30 min to 1 hour
to reach target temperature with current cooling methods
[8,18-20]. In the clinical setting today it is not feasible to
delay reperfusion therapy in order to wait for induction of
hypothermia. The combination of an infusion of cold
saline solution and endovascular cooling achieved a
reduction in temperature to <35°C in approximately five
min (Fig 2). This protocol could be clinically applicable
since it would allow induction of hypothermia before or
during angiography and have the patient cooled to below
35°C without delaying reperfusion therapy.
Infarct size evaluation
Previous studies have used histology with TTC or imaging
with SPECT to visualise the extent of myocardial infarc-
tion. Ex vivo MR imaging has been shown to correlate
This figure illustrates the visual comparison between typical examples from the respective groups Figure 4
This figure illustrates the visual comparison between typical examples from the respective groups. The bottom 
row shows the area at risk measured by SPECT shown in a bull' eye plot of the left ventricle. The top row illustrates the region 
of infarction from ex vivo MRI. White lines denote the slice position of the two ex vivo MRI slices in relation to each other. Note 
the patchy pattern of the myocardial infarction in the MRI image from the pre-reperfusion hypothermia group. In the MRI 
images from the post-reperfusion hypothermia group and most notably, the normothermia group, hypointense zones of micro-
vascular obstruction are seen within the area of infarction.BMC Cardiovascular Disorders 2008, 8:7 http://www.biomedcentral.com/1471-2261/8/7
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closely to TTC-staining in the setting of acute myocardial
infarction with reperfusion for either six hours or one day
[25,32]. Since ex vivo MRI allows higher spatial resolution
(~200 images/heart) compared to TTC-staining, MRI was
chosen as the method for evaluation of infarct size in our
study. SPECT was used to determine area at risk during
ischemia. As shown in figure 3, the placement of the bal-
loon after the first diagonal branch induced ischemia in,
on average 39% of the left ventricle, with no difference in
area at risk between the groups. Ex vivo MRI demonstrated
a more inhomogeneous and patchy appearance of the
myocardial infarctions after pre-reperfusion hypothermia.
Dae et al described similar findings with scattered islands
of reduced Sestamibi uptake in pig hearts when assessing
infarct size with SPECT in pigs subject to endovascular
hypothermia [8]. It is possible that preservation of small
zones of viable myocardium could be beneficial in the
long term by preventing aneurysm formation and by mak-
ing it possible to develop cellular hypertrophy which
could improve contractility in the affected area.
Microvascular injury
Reperfusion therapy that achieves a good angiographic
result after opening of the coronary occlusion may yet
result in persistent ST-segment elevation attributed to
microvascular injury [33]. The degree of microvascular
injury is associated with the duration of myocardial
ischemia and the extent of myocardial infarction but may
possibly also be caused by reperfusion injury. Impor-
tantly, the presence of microvascular obstruction is associ-
ated with a worse clinical outcome [6]. The ultrastructural
alterations associated with microvascular obstruction
consists of swollen endothelium with intraluminal pro-
trusions, tightly packed erythrocytes and increased neu-
trophile adherence [34,35]. In our study, induction of
hypothermia shortly before reperfusion abolished micro-
vascular obstruction while it was prevalent in both hypo-
thermia at the onset of reperfusion and the normothermia
groups (Fig 3). Interestingly, there was a significant reduc-
tion in the size of microvascular obstruction when hypo-
thermia was initiated at the onset of reperfusion
compared to normothermia, possibly due to the rapid
cooling by cold saline. The post-reperfusion cooling was
so rapid that it actually cools during a part of the reper-
fusion period. The duration of this period is difficult to
define, but the reactive hyperemia lasts for ten minutes,
and we reached target temperature already after five min-
utes. Possibly, the reduction in postischemic reactive
hyperemia could be a factor affecting microvascular
obstruction. We recently demonstrated that hypothermia
reduces reactive hyperemia during reperfusion [31].
Together these results suggest that microvascular obstruc-
tion is associated with reperfusion injury and that hypo-
thermia may prevent reperfusion injury.
Interestingly, the reduction in microvascular obstruction
in the post-reperfusion group was not accompanied by a
reduction in infarct size (Figure 3). Previous studies have
not been able to separate these events [36]. For example,
the protective effects of both ischemic preconditioning
and Na+/H+-exchanger inhibition reduces necrosis and
microvascular obstruction to the same extent [36]. How-
ever, Hale et al demonstrated that hypothermia during
ischemia reduced infarct size with more than propor-
tional microvascular protection [15]. Here we support
their findings and demonstrate for the first time that
microvascular obstruction can be reduced without affect-
ing infarct size when hypothermia is induced at the onset
of reperfusion. This suggests separate mechanisms for the
developement of microvascular obstruction and infarct
size. Further studies in this model may be able to dissoci-
ate the mechanisms of microvascular obstruction from
myocardial infarction development.
Hemodynamic measurements
There was a trend towards a lower cardiac output in the
pre-reperfusion hypothermia group after myocardial inf-
arction was induced. The stroke volume remained
unchanged, thus any difference in cardiac output would
be attributed to a difference in heart rate. We did not
measure the core temperature when the MRI was per-
formed. Possibly, the temperature in the pre-reperfusion
hypothermia group could be lower, accounting for the
difference in heart rate. We did not expect to see any acute
improvement in left ventricular function in the hypother-
mia groups since the area at risk between the groups did
not differ, thus the different groups would have had the
same amount of myocardium subject to ischemia. The
benefit in a lower infarct size would be expected during
the time course of days-weeks as the stunned myocardium
would regain function and ventricular remodelling would
be prevented.
Limitations
The methods for ex vivo quantification of patchiness
index and microvascular obstruction are novel methods
that have not been validated as such, however we have
previously shown that ex vivo contrast enhanced T1
weighted MRI, as used in our study, shows excellent agree-
ment with in vivo delayed enhancement MRI [37]. Algo-
rithms similar to that used for patchiness index in this
study have previously been used for quantification and
characterization of myocardial infarction using delayed
enhancement MR imaging [38]. Demonstration, quantifi-
cation and validation of microvascular obstruction in MR
imaging have been performed with microspheres in
experimental models [39] and extensively studied in
humans using both first-pass MR perfusion imaging and
delayed contrast enhanced MR imaging.BMC Cardiovascular Disorders 2008, 8:7 http://www.biomedcentral.com/1471-2261/8/7
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Conclusion
A rapid induction of hypothermia can be achieved by a
combination of cold saline and endovascular cooling.
Such hypothermia induced before reperfusion is effective
in reducing the myocardial infarct size and protecting the
heart from microvascular obstruction. Interestingly, rapid
induction of hypothermia at the onset of reperfusion also
reduced microvascular obstruction with no effect on inf-
arct size. These effects may have significant beneficial
effects on clinical outcome after myocardial infarction.
This protocol can easily be applied to the clinical setting
where hypothermia could be induced before reperfusion
without delaying PCI. However, a rapid infusion of large
volumes of saline solution in patients with myocardial
infarction could have serious side-effects, such as left ven-
tricular overload and pulmonary oedema. A currently
ongoing human safety and feasibility study on patients
with acute myocardial infarction will determine whether
cold saline as an adjunctive therapy to endovascular cool-
ing can be safely administered (RAPID MI-ICE pilot) [40].
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